Raising the bar in haematology drug development
Learn about how Roche’s innovation, heritage and scientific focus help drive significant advances in haematology.more
For more than 20 years, Roche has been developing medicines that redefine treatment in haematology
With more than 60 subtypes, non-Hodgkin lymphoma is a complex group of diseases. Read this article to learn more.more
Learn about the history of lymphoma and why subtypes matter.more
Awareness and understanding of lymphoma is greatly lacking. Visit this infographic to find out more.
Learn about the differences between the two most common types of non-Hodgkin lymphoma in our interactive feature.more
Find out the challenges faced in the treatment of CLL with this infographic depicting a patient’s treatment journey.
Spotlight on MRD: why it is an important endpoint in blood cancer?